$OFLX

Omega Flex, Inc.

Insider trades

No enriched coverage for $OFLX in the last 7 days.

No SEC Form 4 filings for $OFLX in the last 30 days.

See all $OFLX insider activity →
Med

Omega Flex medical tubing receives EU MDR CE mark certification

Omega Flex (NASDAQ: OFLX) reported 2Q26 and six-month 2026 results and said six-month net sales were $47.2M, down 3.5% from $48.9M, while net income fell to $4.8M from $7.7M. The company also announced its Flex-Trac MediTrac corrugated medical tubing received EU MDR CE mark certification (Class IIa) in Aug 2026 and launched a re-engineered TracPipe gas fitting on July 1, 2026.

Omega Flex, Inc. (OFLX): Results of Operations and Financial Condition

Omega Flex, Inc. (OFLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0001317945 0001317945 2026-08-12 2026-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report

Omega Flex, Inc. (OFLX): Submission of Matters to a Vote of Security Holders

Omega Flex, Inc. (OFLX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001317945 0001317945 2026-06-09 2026-06-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report

OFLX sentiment & insider activity

Recent OFLX coverage spans financial news, regulation and earnings.

What's driving OFLX

  • CE mark under EU MDR 2017/745 expands regulatory eligibility for MediTrac CMT in Europe, while earnings show ongoing margin pressure from costs and weaker volumes.

    stocktitan.net · Aug 12, 2026

  • The filing adds a new regulatory milestone (CE Mark) alongside reported operating results, which can shift near-term demand expectations for MediTrac tubing.

    SEC EDGAR 8-K · Aug 12, 2026

  • Board election outcome is routine, but the same filing also announces a regular quarterly dividend, which can affect near-term income/valuation positioning.

    SEC EDGAR 8-K · Jun 11, 2026

  • Omega Flex experienced a significant stock decline of 15.6% following disappointing Q1 2026 earnings, driven by high raw material costs and increased operating expenses. Despite short-term challenges, the company maintains a strong balance sheet and dividend payments, indicating resilience.

    TradingView · May 6, 2026

  • Omega Flex reported a 41.8% decline in net income for Q1 2026, largely due to increased raw material costs and tariffs, despite stable sales. The company is investing in capacity expansion, indicating a focus on future growth.

    Stock Titan · Apr 30, 2026

alphai scores every news story that mentions OFLX with an AI model for sentiment and relevance, and aggregates insider trades from Omega Flex, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $OFLX

Score
$OFLXMedAI 8/10

Omega Flex medical tubing receives EU MDR CE mark certification

Omega Flex (NASDAQ: OFLX) reported 2Q26 and six-month 2026 results and said six-month net sales were $47.2M, down 3.5% from $48.9M, while net income fell to $4.8M from $7.7M. The company also announced its Flex-Trac MediTrac corrugated medical tubing received EU MDR CE mark certification (Class IIa) in Aug 2026 and launched a re-engineered TracPipe gas fitting on July 1, 2026.

$OFLXMed

Omega Flex, Inc. (OFLX): Results of Operations and Financial Condition

Omega Flex, Inc. (OFLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0001317945 0001317945 2026-08-12 2026-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report

$OFLXLow

Omega Flex, Inc. (OFLX): Submission of Matters to a Vote of Security Holders

Omega Flex, Inc. (OFLX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001317945 0001317945 2026-06-09 2026-06-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report

$OFLXMed

Omega Flex Stock Down 16% as Q1 Earnings Tumble Y/Y on High Costs

Omega Flex (OFLX) saw its stock decline 15.6% after reporting a significant drop in Q1 2026 earnings per share and net income, largely due to high raw material costs and increased operating expenses. Despite this, the company maintains a strong balance sheet and continues to pay dividends, focusing on product innovation and liquidity over the next year.

$OFLXMed

Tariffs and raw materials cut Omega Flex net income 41.8%

Omega Flex (NASDAQ: OFLX) reported a significant 41.8% decline in net income for Q1 2026, falling to $2.08 million from $3.57 million a year prior, largely due to increased raw material and tariff costs, and higher marketing and product enhancement expenses. Net sales remained relatively stable at $23.09 million, a slight 1% decrease from Q1 2025. The company is, however, making targeted investments in equipment and facilities to expand capacity and support future growth.

$OFLXLow

OFLX SEC Filings - Omega Flex 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Omega Flex (OFLX) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms. It features AI-powered summaries to highlight key points from these regulatory documents for investors. Recent filings detail CEO phantom stock awards, institutional ownership updates, and quarterly financial results for Q3 and Q2 2025.

$OFLXMed

Omega Flex, Inc. (NASDAQ:OFLX) Short Interest Down 25.8% in February

Omega Flex, Inc. (NASDAQ:OFLX) experienced a significant 25.8% decrease in short interest during February, settling at 80,574 shares, which represents about 2.3% of its total shares sold short. The company's director, Stephen M. Shea, recently increased his stake by purchasing additional shares, and insiders collectively own over 65% of the stock. Despite a "Sell" rating from analysts, the stock trades near $37.31 with a market cap of $376.5 million and offers a 3.6% dividend yield.

Related tickers